| Lauren Nicole Hinojosa, MD | |
|
525 Blossom St, Webster, TX 77598-4209 | |
| (832) 905-4186 | |
| (832) 753-7457 |
| Full Name | Lauren Nicole Hinojosa |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 16 Years |
| Location | 525 Blossom St, Webster, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033379284 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0105X | Surgery - Surgery Of The Hand | P2121 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Physicians' Hospital | Webster, TX | Hospital |
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lauren Hinojosa Md Pa | 2365721693 | 2 |
News Archive
Cornell University experts on farm animals and food safety comment on the recall of at least 380 million eggs in the past week due to concerns over salmonella contamination.
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Research from Western University (London, Canada) has revealed a possible new target for treating movement disorders such as Huntington's disease (HD) and Parkinson's disease. Stephen Ferguson, PhD, a scientist at Western's Robarts Research Institute, and Fabiola Ribeiro, PhD, of the Universidade Federal de Minas Gerais in Brazil found a definite improvement in motor behaviors in a HD mouse model when one of the major neurotransmitters in the brain, called Metabotropic Glutamate Receptor 5 (mGluR5) was deleted.
› Verified 4 days ago
| Entity Name | Lauren Hinojosa Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639626856 PECOS PAC ID: 2365721693 Enrollment ID: O20161109001598 |
News Archive
Cornell University experts on farm animals and food safety comment on the recall of at least 380 million eggs in the past week due to concerns over salmonella contamination.
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Research from Western University (London, Canada) has revealed a possible new target for treating movement disorders such as Huntington's disease (HD) and Parkinson's disease. Stephen Ferguson, PhD, a scientist at Western's Robarts Research Institute, and Fabiola Ribeiro, PhD, of the Universidade Federal de Minas Gerais in Brazil found a definite improvement in motor behaviors in a HD mouse model when one of the major neurotransmitters in the brain, called Metabotropic Glutamate Receptor 5 (mGluR5) was deleted.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Nicole Hinojosa, MD 525 Blossom St, Webster, TX 77598-4209 Ph: (832) 905-4186 | Lauren Nicole Hinojosa, MD 525 Blossom St, Webster, TX 77598-4209 Ph: (832) 905-4186 |
News Archive
Cornell University experts on farm animals and food safety comment on the recall of at least 380 million eggs in the past week due to concerns over salmonella contamination.
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Research from Western University (London, Canada) has revealed a possible new target for treating movement disorders such as Huntington's disease (HD) and Parkinson's disease. Stephen Ferguson, PhD, a scientist at Western's Robarts Research Institute, and Fabiola Ribeiro, PhD, of the Universidade Federal de Minas Gerais in Brazil found a definite improvement in motor behaviors in a HD mouse model when one of the major neurotransmitters in the brain, called Metabotropic Glutamate Receptor 5 (mGluR5) was deleted.
› Verified 4 days ago
Mr. Yevgeny Shuhatovich, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 905 W Medical Center Blvd # 404, Webster, TX 77598 Phone: 281-985-9342 Fax: 281-393-0029 | |
Shitel Dineshbhai Patel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 210 Genesis Blvd # B, Webster, TX 77598 Phone: 832-835-1131 Fax: 832-918-3223 | |
Hoang Pham, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 350 N Texas Ave, Suite A2, Webster, TX 77598 Phone: 281-616-6017 Fax: 281-947-3037 | |
In Soo Yo, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 450 W Medical Center Blvd, #600, Webster, TX 77598 Phone: 281-332-4596 Fax: 281-332-9610 | |
Keyan Mobli, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 250 Blossom St Fl 4, Webster, TX 77598 Phone: 832-505-4000 Fax: 832-632-7866 | |
Tamer Dafashy, MD Surgery Medicare: Medicare Enrolled Practice Location: 150 E Medical Center Blvd Ste C, Webster, TX 77598 Phone: 281-316-4978 Fax: 281-316-2192 |